A PSP94-derived Peptide PCK3145 inhibits MMP-9 Secretion and Triggers CD44 Cell Surface Shedding: Implication in Tumor Metastasis-Reference-Cited by-同舟云学术

A PSP94-derived Peptide PCK3145 inhibits MMP-9 Secretion and Triggers CD44 Cell Surface Shedding: Implication in Tumor Metastasis

Published:2005-09 Issue:5 Volume:22 Page:429-439
ISSN:0262-0898
Container-title:Clinical & Experimental Metastasis
language:en
Short-container-title:Clin Exp Metastasis

Author:

Annabi Borhane,Bouzeghrane Mounia,Currie Jean-Christophe,Hawkins Robert,Dulude Hélène,Daigneault Luc,Ruiz Marcia,Wisniewski Jan,Garde Seema,Rabbani Shafaat A.,Panchal Chandra,Wu Jinzi J.,Béliveau Richard

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10585-005-2669-1.pdf

Reference52 articles.

1. Modulation of the Organ Microenvironment for Treatment of Cancer Metastasis

2. DETECTION OF PSP94 AND ITS SPECIFIC BINDING SITES IN THE PROSTATE ADENOCARCINOMA CELL LINE LNCaP

3. Prognostic significance of ?-microseminoprotein mRNA expression in prostate cancer

4. A Synthetic 15-mer Peptide (PCK3145) Derived from Prostate Secretory Protein Can Reduce Tumor Growth, Experimental Skeletal Metastases, and Malignancy-Associated Hypercalcemia

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics;eBioMedicine;2024-07

2. Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics;2023-09-22

3. Polyester nanomedicines targeting inflammatory signaling pathways for cancer therapy;Biomedicine & Pharmacotherapy;2022-10

4. CD44 In Sarcomas: A Comprehensive Review and Future Perspectives;Frontiers in Oncology;2022-06-17

5. Exploiting Hyaluronan-CD44 Network in Tumor Therapy;The Extracellular Matrix and the Tumor Microenvironment;2022